Medtech grants in South Korea

Closed

Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.

Open

Funds Korean startups and small and medium-sized enterprises through low-interest loans managed by KOSME and the Ministry of enterprise and innovation support.

Between cycles

Funds Korean startups building products and market access with global companies through open-innovation projects.

Between cycles

Funds Korean venture-stage companies with market-development support and loan guarantees to accelerate scaling.

Between cycles

Funds Korean SMEs entering overseas markets through projects run with companies that already have global channels.

Between cycles

Funds Korean startups solving defined technology problems with large companies and public institutions.

Closed

Supports foreign-founded startups entering Korea with market localization and expansion assistance.

Closed

Funds Korean micro-enterprises turning proven export demand into products, brands, certifications, and overseas sales.

Gives free mentoring and pitch coaching to international student founders building in Korea.

Closed

Funds high-growth Korean technology companies scaling overseas, raising global capital, and preparing for public markets.

Discontinued

Provides collateral-light access to bank financing in Korea through technology-based credit guarantees for innovative startups and small businesses.

Open

Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.

Open

Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.

Open

Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.

Offers $200,000 in prizes across five enterprise challenge streams for teams building quantum, AI and HPC solutions to real industrial problems.

Open

Awards $1 million to one winning mental-health research team, and $250,000 each to three runners-up, developing new interventions for anxiety, depression or psychosis, worldwide.

Open

Funds a consortium to build a new EIT Label-certified micro-credentials programme teaching entrepreneurship and innovation to healthcare students.

Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.

Open

Funds a £6.25 million challenge prize for innovations that improve snakebite outcomes worldwide.

Open

Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.

Open

Funds high-risk clinical trials of new ways to see inside the living human inner ear. A trial is compulsory, and NIH stays in the room.

Open

Funds building the imaging that can finally show hair cells and membranes inside a living human ear. A clinical trial is optional.

Open

Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.

Pays photonics startups up to $10,000 for pitching live at SPIE Photonics West.